C. I. Fincham

发表

Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 1: hit identification.

M. Binaschi, C. Maggi, D. Fattori, 2013, Bioorganic & medicinal chemistry letters.

Bradykinin receptor antagonists – a review of the patent literature 2005 – 2008

D. Fattori, C. I. Fincham, M. Paris, 2009, Expert opinion on therapeutic patents.

Amide bond replacements incorporated into CCK-B selective "dipeptoids".

D. Rees, C. I. Fincham, D. Horwell, 1992, Journal of medicinal chemistry.

Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships of α,α-tetrahydropyranylglycine.

C. Maggi, A. Ettorre, C. I. Fincham, 2012, Bioorganic & medicinal chemistry.

New conformationally homogeneous β‐turn antagonists of the human B2 kinin receptor

R. Terracciano, C. I. Fincham, E. Monteagudo, 2001, Journal of peptide science : an official publication of the European Peptide Society.

Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist.

R. Terracciano, C. I. Fincham, M. Parlani, 1998, European journal of pharmacology.

4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors.

M. Binaschi, C. Maggi, D. Fattori, 2011, Bioorganic & medicinal chemistry letters.

Structure-activity relationships and spectroscopic insights into a series of retro-inverso Tachykinin NK-1 receptor antagonists

R. Terracciano, A. Sisto, M. Venanzi, 2002 .

Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors.

M. Binaschi, C. Maggi, D. Fattori, 2011, Bioorganic & medicinal chemistry letters.

Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK1 receptor antagonist

R. Terracciano, C. Maggi, A. Sisto, 2001, Neuropeptides.

Synthesis and biological evaluation of novel NK‐1 tachykinin receptor antagonists: The use of cycloalkyl amino acids as a template

A. Sisto, C. Maggi, C. Goso, 1995, Biopolymers.

Fragment-based drug design: combining philosophy with technology.

D. Fattori, S. Bartoli, C. I. Fincham, 2007, Current opinion in drug discovery & development.

The use of a proline ring as a conformational restraint in CCK-B receptor “dipeptoids”.

D. Rees, C. I. Fincham, D. Horwell, 1992 .

Design and Synthesis of Novel Sulfonamide-Containing Bradykinin hB2 Receptor Antagonists. 2. Synthesis and Structure−Activity Relationships of α,α-Cycloalkylglycine Sulfonamides

R. Terracciano, C. Maggi, D. Fattori, 2007 .

Design and Synthesis of Novel Sulfonamide-Containing Bradykinin hB2 Receptor Antagonists. 1. Synthesis and SAR of α,α-Dimethylglycine Sulfonamides

R. Terracciano, C. Maggi, D. Fattori, 2006 .

Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 2. Synthesis and structure-activity relationships of alpha,alpha-cycloalkylglycine sulfonamides.

R. Terracciano, C. Maggi, D. Fattori, 2007, Journal of medicinal chemistry.

Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides.

R. Terracciano, C. Maggi, D. Fattori, 2006, Journal of medicinal chemistry.

The fragment-approach: An update

D. Fattori, S. Bartoli, C. I. Fincham, 2006 .